Achieve Life Sciences (ACHV) Net Cash Flow (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Net Cash Flow data on file, last reported at $7.4 million in Q1 2026.

• Quarterly Net Cash Flow rose 2679.25% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.0 million (down 281.44% YoY) and the FY2025 annual result came in at $8.1 million, up 388.27% from the prior year.
• Net Cash Flow improved to $7.4 million in Q1 2026, from -$11.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $50.8 million in Q1 2024 to a low of -$19.9 million in Q3 2025.
• A 5-year average of -$555000.0 and a median of -$5.1 million in 2024 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2025 — Net Cash Flow sank 443.93% — and 2026, when it soared 2679.25%.
• Tracing ACHV's Net Cash Flow over 5 years: stood at $6.6 million in 2022, then tumbled by 166.51% to -$4.4 million in 2023, then surged by 173.46% to $3.2 million in 2024, then slumped by 443.93% to -$11.0 million in 2025, then surged by 166.71% to $7.4 million in 2026.
• The last three Net Cash Flow figures came in at $7.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$19.9 million (Q3 2025), per Business Quant data.